Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday? – Benzinga

Cancer-focused penny stock Viracta Therapeutics saw an increase in trading on Wednesday. The reason for this surge is not entirely clear, but it could be due to positive news or developments within the company. Viracta Therapeutics specializes in developing treatments for cancer, making it an attractive option for investors looking to capitalize on the growing demand for cancer therapies. As a penny stock, Viracta Therapeutics may offer investors the potential for high returns, but also comes with higher risk. It is important for investors to conduct thorough research and consider the risks before investing in penny stocks like Viracta Therapeutics.